![Pia E. Ringholm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pia E. Ringholm
Geen lopende functies
Profiel
Pia E.
Ringholm formerly worked at Zymenex A, as Quality Director from 2000 to 2011, Christian Hansen Holding A, as Manager, ALK-Abello A, as Principal, and LEO Pharma A, as Manager.
Ms. Ringholm received her graduate degree from Danmarks Farmaceutiske Universitet.
Eerdere bekende functies van Pia E. Ringholm
Bedrijven | Functie | Einde |
---|---|---|
ALK-ABELLÓ A/S | Corporate Officer/Principal | - |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Christian Hansen Holding A/S | Corporate Officer/Principal | - |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Algemeen Adviseur | - |
Opleiding van Pia E. Ringholm
Danmarks Farmaceutiske Universitet | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALK-ABELLÓ A/S | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Christian Hansen Holding A/S | Consumer Non-Durables |